• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors

    5/16/24 6:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care
    Get the next $HIMS alert in real time by email

    Manuel joins Hims & Hers board of directors to help the company further innovate and increase access to healthcare for millions within the personalized health and wellness space

    Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Anja Manuel to the company's Board of Directors. Ms. Manuel is a co-founder and principal in Rice, Hadley, Gates & Manuel LLC, a strategic consulting firm founded in 2009 that helps U.S. companies navigate international markets and regulatory issues, and a former U.S. government official.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240516913614/en/

    Manuel joins Hims & Hers board of directors to help the company further innovate and increase access to healthcare for millions within the personalized health and wellness space. (Photo: Business Wire)

    Manuel joins Hims & Hers board of directors to help the company further innovate and increase access to healthcare for millions within the personalized health and wellness space. (Photo: Business Wire)

    "Anja is a remarkable leader and visionary who brings extensive experience to our board working in the areas of government relations, foreign policy, technology policy, international markets, and governance matters. Her knowledge and background, combined with that of our current directors, will further accelerate our mission to help the world feel great through the power of better health," said Andrew Dudum, CEO and co-founder of Hims & Hers. "As we continue to improve our access to more personalized care in the U.S. and pursue our ambitions of global expansion in the coming years, Anja's expertise in regulation and international policy will be invaluable in our next phase of growth."

    "Hims & Hers is making a tremendous impact on the U.S. healthcare industry by improving personalized care for conditions that affect millions," said Anja Manuel. "I look forward to helping build on the already strong foundation of this company and helping to guide how the team approaches international opportunities in the future."

    In addition to co-leading RHGM LLC, Ms. Manuel is an experienced board member. She currently serves on the board of Ripple Labs, Inc., a privately held leading blockchain payments company, since 2017. She served as a director of Overseas Shipping Group, Inc., a NYSE-listed transportation company, from June 2017 to June 2023, and is a member of several advisory boards of private companies, foundations and governmental entities.

    Ms. Manuel is also the Executive Director of the Aspen Strategy Group and Aspen Security Forum, a premier bi-partisan forum on foreign policy in the U.S. Additionally, she previously served as a diplomat in the U.S. State Department, as an attorney at WilmerHale, and as an investment banker at Salomon Brothers. Ms. Manuel is the author of the critically acclaimed This Brave New World: India, China and the United States, published by Simon and Schuster, and numerous articles and papers. She also lectured and was a research affiliate at Stanford University from 2009-2019, teaching courses on U.S. Foreign Policy in Asia and Technology Policy. Ms. Manuel received a B.A and M.A. in International Relations with distinction from Stanford University and a J.D. cum laude from Harvard Law School.

    About Hims & Hers Health, Inc

    Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That's why we're building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit www.hims.com and www.forhers.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240516913614/en/

    Get the next $HIMS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HIMS

    DatePrice TargetRatingAnalyst
    6/23/2025Buy → Hold
    Needham
    6/4/2025$61.00 → $65.00Buy
    Needham
    4/29/2025$30.00Buy → Hold
    TD Cowen
    2/18/2025$42.00 → $60.00Overweight → Equal-Weight
    Morgan Stanley
    1/10/2025$24.00 → $25.00Neutral → Sell
    Citigroup
    1/7/2025$35.00Buy
    BTIG Research
    12/17/2024$42.00Overweight
    Morgan Stanley
    11/14/2024Buy → Underperform
    BofA Securities
    More analyst ratings

    $HIMS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hims & Hers Health downgraded by Needham

      Needham downgraded Hims & Hers Health from Buy to Hold

      6/23/25 11:43:05 AM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • Needham reiterated coverage on Hims & Hers Health with a new price target

      Needham reiterated coverage of Hims & Hers Health with a rating of Buy and set a new price target of $65.00 from $61.00 previously

      6/4/25 7:59:55 AM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • Hims & Hers Health downgraded by TD Cowen with a new price target

      TD Cowen downgraded Hims & Hers Health from Buy to Hold and set a new price target of $30.00

      4/29/25 8:05:51 AM ET
      $HIMS
      Medical/Nursing Services
      Health Care

    $HIMS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Manuel Anja bought $132,260 worth of shares (5,000 units at $26.45) (SEC Form 4)

      4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

      11/14/24 4:57:45 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • Payne Christopher D bought $1,951,763 worth of shares (110,000 units at $17.74) (SEC Form 4)

      4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

      5/22/24 4:16:26 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care

    $HIMS
    SEC Filings

    See more
    • SEC Form 144 filed by Hims & Hers Health Inc.

      144 - Hims & Hers Health, Inc. (0001773751) (Subject)

      6/23/25 4:49:30 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • Hims & Hers Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Hims & Hers Health, Inc. (0001773751) (Filer)

      6/17/25 4:49:57 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care
    • Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities

      8-K - Hims & Hers Health, Inc. (0001773751) (Filer)

      5/13/25 5:23:44 PM ET
      $HIMS
      Medical/Nursing Services
      Health Care